Literature DB >> 23468278

Dopa-responsive dystonia is caused by particular impairment of nigrostriatal dopamine neurons different from those involved in Parkinson disease: evidence observed in studies on Segawa disease.

Masaya Segawa1, Yoshiko Nomura, Masaharu Hayashi.   

Abstract

From the characteristics of its clinical features, Segawa disease is considered to be caused by deficiency of the tyrosine hydroxylase (TH) of the nigrostriatal dopamine neurons, which have high TH activities in the terminal but not in the perikaryon. This hypothesis was confirmed by two autopsied cases. However, these cases were younger than 40 years and left a question as to whether these abnormalities turned to those of Parkinson disease in older ages. An autopsy of a 90-year-old woman with Segawa disease confirmed the hypothesis that Segawa disease has a completely different pathophysiology and pathology than Parkinson disease. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23468278     DOI: 10.1055/s-0033-1337337

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  10 in total

Review 1.  Dopa-responsive dystonia, DRD-plus and DRD look-alike: a pragmatic review.

Authors:  Ajith Cherian; Naveen Kumar Paramasivan; K P Divya
Journal:  Acta Neurol Belg       Date:  2021-01-16       Impact factor: 2.396

2.  Parkinsonism without dopamine neuron degeneration in aged l-dopa-responsive dystonia knockin mice.

Authors:  Samuel J Rose; Porter Harrast; Christine Donsante; Xueliang Fan; Valerie Joers; Malú G Tansey; H A Jinnah; Ellen J Hess
Journal:  Mov Disord       Date:  2017-09-26       Impact factor: 10.338

Review 3.  Dopa-responsive dystonia--clinical and genetic heterogeneity.

Authors:  Subhashie Wijemanne; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2015-06-23       Impact factor: 42.937

Review 4.  Recognizing Atypical Dopa-Responsive Dystonia and Its Mimics.

Authors:  Philippe A Salles; Mérida Terán-Jimenez; Alvaro Vidal-Santoro; Pedro Chaná-Cuevas; Marcelo Kauffman; Alberto J Espay
Journal:  Neurol Clin Pract       Date:  2021-12

5.  Recessive GCH1 Deficiency Causing DOPA-Responsive Dystonia Diagnosed by Reported Negative Exome.

Authors:  Seth I Berger; Ilana Miller; Laura Tochen
Journal:  Pediatrics       Date:  2022-02-01       Impact factor: 7.124

Review 6.  Pathogenesis of dystonia: is it of cerebellar or basal ganglia origin?

Authors:  Ryuji Kaji; Kailash Bhatia; Ann M Graybiel
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-10-31       Impact factor: 10.154

7.  An MRI method for parcellating the human striatum into matrix and striosome compartments in vivo.

Authors:  J L Waugh; Aao Hassan; J K Kuster; J M Levenstein; S K Warfield; N Makris; N Brüggemann; N Sharma; H C Breiter; A J Blood
Journal:  Neuroimage       Date:  2021-11-18       Impact factor: 7.400

Review 8.  Combined dystonias: clinical and genetic updates.

Authors:  Anne Weissbach; Gerard Saranza; Aloysius Domingo
Journal:  J Neural Transm (Vienna)       Date:  2020-10-24       Impact factor: 3.575

9.  Reply: Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.

Authors:  Niccolo E Mencacci; Alan M Pittman; Ioannis U Isaias; John Hardy; Stephan Klebe; Kailash P Bhatia; Nicholas W Wood
Journal:  Brain       Date:  2014-11-14       Impact factor: 13.501

10.  Nucleotide Variants of the BH4 Biosynthesis Pathway Gene GCH1 and the Risk of Orofacial Clefts.

Authors:  Kamil K Hozyasz; Adrianna Mostowska; Piotr Wójcicki; Agnieszka Lasota; Małgorzata Zadurska; Izabela Dunin-Wilczyńska; Paweł P Jagodziński
Journal:  Mol Neurobiol       Date:  2015-07-28       Impact factor: 5.590

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.